RESEARCH-USE BIOSIMILAR ANTIBODY

Tarcocimab

Monoclonal antibody · IgG1

VEGFAIgG1RUO

Tarcocimab (OG1953) is a humanized anti-VEGFA monoclonal antibody (IgG1 type). Tarcocimab is available for research in retinal vein occlusion (RVO) and wet age-related macular degeneration (AMD).

TARGETVEGFA
YMonoclonal antibody
CATALOGSC-BS-132
CATALOG NUMBERSC-BS-132
MOLECULAR WEIGHTApprox. 146.27 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tarcocimab (OG1953) is a humanized anti-VEGFA monoclonal antibody (IgG1 type). Tarcocimab is available for research in retinal vein occlusion (RVO) and wet age-related macular degeneration (AMD).

Tarcocimab is a recombinant research-use antibody directed against VEGFA.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tarcocimab | StellaCyte